PAVmed Inc expected to post earnings of $1.98 a share - Earnings Preview

PAVmed

12/11/2024 03:50

* PAVmed Inc  PAVM.OQ   PAVM.O  is expected to show a rise
in
quarterly revenue when it reports  results on November 13 for
the period ending September 30 2024
    * The New York City-based  company is expected to report a
38.2% increase in revenue to $1.093 million from $791 thousand a
year ago, according to the mean estimate from 3 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for PAVmed Inc is for
earnings of
$1.98 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for PAVmed Inc
is
$4.00​, above​ its last closing price of $1.12. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -1.48       -1.45      -1.19     Beat    18.1
 Mar. 31 2024  -1.77       -1.67      -2.62     Missed  -56.6
 Dec. 31 2023  -1.47       -1.89      -1.81     Beat    4.2​
 Sep. 30 2023  -2.04       -2.05      -2.40     Missed  -17.1
 ​​Jun.        -2.84       -2.85      -2.10     Beat    26.3
 30 2023                                                
 Mar. 31 2023  -3.11       -3.10      -2.85     Beat    8.1​
 Dec. 31 2022  -3.84       -3.80      -3.45     Beat    9.2
 Sep. 30 2022  -3.98       -3.97      -4.35     Missed  -9.4
 This summary was machine generated November 12 at 03:49 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)